期刊文献+

神经干细胞移植治疗帕金森病21例 被引量:3

Treatment of Parkinson disease by implantation of neural stem cells into stratums(report of 21 cases)
下载PDF
导出
摘要 目的观察神经干细胞移植治疗帕金森病患者的效果。方法选取2006年1月至2008年12月我院收治的帕金森病患者21例[男15例,女6例;平均年龄(57.23±9.13)岁]。患者均签署知情同意书,所有患者住院治疗。靶点定位于纹状体,注入神经干细胞0.25 ml,细胞数量为3×107个。结果 21例患者出院后随访6~49个月,与治疗前相比,治疗后21例患者统一帕金森病评定量表评分、Hoehn-Yahr量表评分、39项帕金森生存质量问卷评分明显降低(P〈0.01),Schwab-England量表评分明显升高(P〈0.01)。结论神经干细胞移植可以在一定程度上改善帕金森病患者的临床症状,提高其生活质量。 Objective To observe the curative effect of neural stem cells (NSCs) implantation into stratums on Parkinson disease. Methods NSCs (dose, 0.25 ml containing 3x107 NSCs) were transplanted into the striatums in each of 21 patients with Parkinson disease (age range, 42-79 year; mean age, 57.33 years) treated in Navy General Hospital from January, 2006 to December, 2008, of whom, 15 were males and 6 females. The neural function and life quality in all the patients were assessed by Unified Parkinson's Disease Rating Scale (UPDRS), Hoehn-Yahr Scale, Parkinson's Disease Questionaire (PDQ-39) and Schwab-England Scale before the transplantation and from 6 to 49 months (mean, 24.9 months) after the transplantation. Results The scores of UPDRS, the Hoehn-Yahr scale and PDQ-39 were significantly lower 6 months after the transplantation than those before the transplantation in the 21 patients (P〈0.01). The scores of Schwab-England Scale was significantly higher 6 months after the transplantation than those before the transplantation in all the patients (P〈0.01). Clinical symptoms such as tremor, rigidity, slow movement, unstable posture and so on were significantly improved after the transplantation in all the patients. Conclusions The clinical symptoms may be relieved and the life quality may be improved by the transplantation of NSCs into the striatums in the patients with Parkinson disease.
出处 《中国临床神经外科杂志》 2014年第7期412-413,417,共3页 Chinese Journal of Clinical Neurosurgery
关键词 帕金森病 神经干细胞 移植 效果 Parkinson disease Neural stem cells transplantation Curative effect
  • 相关文献

参考文献12

  • 1Gage FH.Mammalian neural stem cell [J].Science,2000,287(5457):1433-1438.
  • 2杨树源,安沂华.再述神经干细胞的研究及其应用前景[J].中华神经外科杂志,2002,18(5):273-274. 被引量:8
  • 3Kawasaki H,Mizuseki K,Nishikawa S,et al.Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity [J].Neuron,2000,28(1):31-40.
  • 4段凯,唐瑛.自噬在帕金森病中作用的研究进展[J].华南国防医学杂志,2011,25(1):71-73. 被引量:4
  • 5周芳,刁波,段凯,范圳涛,张宜.半夏总生物碱对帕金森病大鼠学习记忆功能的影响及其机制的初步探讨[J].中国临床神经外科杂志,2011,16(7):413-416. 被引量:12
  • 6Mckay R.Stem cells in the central nervous system [J].Sci-ence,1997,176:66-71.
  • 7Gage FH.Mammalian neural stem cell [J].Science,2000,287(5457):1433-1438.
  • 8Kitayama T,Onitsuka Y,Song L,et al.Assessing an eating disorder indueed by 6-OHDA and the possibility of nerve regeneration therapy by transplantation of neural progenitor cells in rats [J].Nihon Shinkei Seishin Yakurigaku Zasshi,2007,27(3):109-116.
  • 9Amariglio N,Hershberg A,Scheichauer BW,et al.Donor-derived brain tumor following neural stem cell transplanta-tion in an ataxia telangieetasia patients [J].PLoS Med,2009,6(2):29.
  • 10Katsube K,Sakamoto K.Notch in vertebrates-molecular aspects of the signal [J].Int J Dev Biol,2005,49(2-3):369.

二级参考文献40

  • 1范国华,陈生弟,曹文俊,赵静.帕金森病模型中热休克蛋白mRNA的表达[J].中华神经科杂志,2006,39(4):266-268. 被引量:2
  • 2王光明,周蓉.半夏的中药药理研究进展[J].中医药导报,2007,13(2):97-99. 被引量:63
  • 3彭敏,姚树桥,朱熊兆,黄彦祷.热休克蛋白70在神经元可塑性中作用的研究进展[J].中国行为医学科学,2007,16(2):184-186. 被引量:3
  • 4Bandhyopadhyay U,Cuervo AM.Chaperone-mediated autophagy in aging and neurodegeneration:lessons from alpha-synuclein[J].Exp Gerontol,2007,42(1-2):120-128.
  • 5Olanow CW,McNaught KS.Ubiquitin-proteasome system and Parkinson's disease[J].Mov Disord,2006,21(11):1806-1823.
  • 6Lee SB,Kim S,Lee J,et al.ATGI,an autophagy regulator,inhibits Cell growth by negatively regulating S6kinase[J].EMBO Rep,2007,8(4):360-365.
  • 7Wullsehleger S,Loewith R,Oppliger W,et al.Molecular organization of target of rapamycin complex2[J].J Biol Chem,2005,280(35):30697-30704.
  • 8Cuervo AM,Stefanis L,Fredenburg R,et al.Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy[J].Science,2004,305(5688):1292-1295.
  • 9Vogiatzi T,Xilouri M,Vekrellis K,et al.Wild type alpha-synuclein is degraded by chaperone-mediated autophagy and macroautophagy in neuronal cells[J].J Biol Chem,2008,283(35):23542-23556.
  • 10Kabuta T,Furuta A,Aoki S,et al.Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy[J].J Biol Chem,2008,283(35):23731-23738.

共引文献21

同被引文献76

  • 1郑江环,宁丽洁,钟传林,吴建波.应用神经干细胞移植术治疗帕金森氏病的临床疗效观察[J].求医问药(下半月),2013(10):143-144. 被引量:1
  • 2朱剑虹.神经干细胞和人脑再生医学[J].中华医学杂志,2005,85(36):2527-2529. 被引量:6
  • 3张振馨.帕金森病的诊断[J].中华神经科杂志,2006,39(6):408-409. 被引量:614
  • 4HOANG QUYEN Q. Pathway for Parkinson disease[ J]. Proc Natl Acad Sci U S A, 2014, 111(7) : 2402 -2403.
  • 5DECRESSAC M, VOLAKAKIS N, BJORKLUND A, et al. NURR1 in Parkinson disease from pathogenesis to therapeutic po- tential[J]. Nat RevNeurol, 2013, 9(11): 629-636.
  • 6NOLAN Y M, SULLIVAN A M, TOULOUSE A. Parkinson's di- sease in the nuclear age of neuroinflammaTion [ J ]. Trends Mol Med, 2013, 19(3) : 187 -196.
  • 7WANG Z, BENOIT G, LIU J, et al. Structure and function of Nurrl identifies a class of ligand independent nuclear receptors [J]. Nature, 2003, 423(6939): 555-560.
  • 8GALLASTEGUI N, MACKINNON J A, FLETTERICK R J, et al. Advances in our structural understanding of orphan nuclear recep- tors[J]. Trends Biochem Sci, 2015, 40(1) : 25 -35.
  • 9KADKHODAEI B, ALVARSSON A, SCHINTU N, et al. Tran- scription factor Nurrl maintains fiber integrity and nuclear - enco- ded mitochondrial gene expression in dopamine neurons [ J 1. Proc Natl Acad Sci U S A, 2013, 110(6) : 2360 -2365.
  • 10LI Y, QI Q, CONG B, et al. Expression patterns of Nun'l in rat retina development [ J ]. J Mol Histol, 2012, 43 (6) : 633 - 639.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部